Persevere Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Persevere Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine (NCT03854110) | Persevere Therapeutics Inc. | 2019-01-14 |
Track Persevere Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.